Jensen L S, Krarup N, Juhl C O, Nielsen T H, Larsen J A
Surgical Gastroenterological Dept. L, Aarhus Kommunehospital, Denmark.
Scand J Gastroenterol. 1989 Mar;24(2):213-22. doi: 10.3109/00365528909093039.
The effect of long-term propranolol administration on esophageal varices, portocollateral shunting, portal pressure, hepatosplanchnic hemodynamics, and liver function was studied in a pig model with experimentally induced prehepatic portal hypertension and esophageal varices. Five pigs were treated with 160 mg propranolol daily from week 5 to week 24 after portal-vein banding, and five pigs served as nontreated controls. Administration of propranolol caused an initial, significant reduction (20%) of portal venous pressure, followed by a gradual increase to levels not different from control pressures. In contrast, a marked reduction of the caliber of the coronary vein and size of the esophageal varices was noticed. Twenty weeks of propranolol treatment did not change liver blood flow or liver function. We conclude that the size of the varices rather than portal venous pressure depicts the effect of propranolol treatment and suggest that the beneficial effect of propranolol on variceal bleeding can be explained by a reduction in the wall tension of the varices, initiated and maintained by a diminution of splanchnic blood flow.
在一个通过实验诱导肝前性门静脉高压和食管静脉曲张的猪模型中,研究了长期给予普萘洛尔对食管静脉曲张、门体分流、门静脉压力、肝内脏血流动力学和肝功能的影响。五只猪在门静脉结扎后第5周开始至第24周,每天接受160mg普萘洛尔治疗,五只猪作为未治疗的对照。给予普萘洛尔后,门静脉压力最初显著降低(20%),随后逐渐升高至与对照压力无差异的水平。相比之下,观察到冠状静脉口径和食管静脉曲张大小显著减小。普萘洛尔治疗20周未改变肝血流量或肝功能。我们得出结论,静脉曲张的大小而非门静脉压力描绘了普萘洛尔治疗的效果,并表明普萘洛尔对静脉曲张出血的有益作用可以通过内脏血流量减少引发和维持的静脉曲张壁张力降低来解释。